Synthesis and anti-inflammation evaluation of new C60 fulleropyrrolidines bearing biologically active xanthine

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 1, 2008, Pages 99-103

  Huang, Sheng Tung ^a   Liao, Jian Sheng ^a   Fang, Hsu Wei ^a   Lin, Chun Mao ^b  

^a NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anti inflammation; C60 fulleropyrrolidine; Nitric oxide; TNF ; Xanthine

Indexed keywords

CARBON; FULLERENE DERIVATIVE; FULLEROPYRROLIDINE DERIVATIVE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PYRROLIDINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XANTHINE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STRUCTURE ANALYSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE, TUMOR; FULLERENES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; PYRROLIDINES; TUMOR NECROSIS FACTOR-ALPHA; XANTHINES;

EID: 37549031723     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.11.004     Document Type: Article

References (47)

1. Tagmatarchis N., and Shinohara H. Mini-Rev. Med. Chem. 1 (2001) 339
2. Sagman U. Perspect. Fullerene Nanotech. (2002) 145
3. Bosi S., Da Ros T., Spalluto G., and Prato M. Eur. J. Med. Chem. 38 (2003) 913
4. Satoh M., and Takayanagi I. J. Pharmacol. Sci. 100 (2006) 513
5. Sayes C.M., Fortner J.D., Guo W., Lyon D., Boyd A.M., Ausman K.D., Tao Y.J., Sitharaman B., Wilson L.J., Hughes J.B., West J.L., and Colvin V.L. Nano Lett. 4 (2004) 1881
6. Dugan L.L., Lovett E., Cuddihy S., Ma B.-W., Lin T.-S., and Choi D.W. Fullerene Chem. Phys. Technol. (2000) 467
7. Song T., Goh S.H., and Lee S.Y. Macromolecules 35 (2002) 4133
8. Gutierrez-Nava M., Accorsi G.P., Masson P., Armaroli N., and Nierengarten J.-F. Chem. Eur. J. 10 (2004) 5076
9. Bosi S., Da Ros T., Spalluto G., and Prato M. Eur. J. Med. Chem. 38 (2003) 913
10. Yang J., and Barron A.R. Chem. Commun. (2004) 2884
11. Sofou P., Elemes Y., Panou-Pomonis E., Stavrakoudis A., Tsikaris V., Sakarellos C., Sakarellos-Daitsiotis M., Maggini M., Formaggio F., and Toniolo C. Tetrahedron 60 (2004) 2823
12. Rouse J.G., Yang J., Barron A.R., and Monteiro-Riviere N.A. Toxicol. In Vitro 20 (2006) 1313
13. Yang J., Alemany L.B., Driver J., Hartgerink J.D., and Barron A.R. Chem. Eur. J. 13 (2007) 2530
14. Da Ros T., Bergamin M., Vazquez E., Spalluto G., Baiti B., Moro S., Boutorine A., and Prato M. Eur. J. Org. Chem. 3 (2002) 405
15. Imahori H., and Fukuzumi S. Adv. Funct. Mater. 14 (2004) 525
16. Guldi D.M. Pure Appl. Chem. 75 (2003) 1069
17. Diederich F. Chimia 55 (2001) 821
18. de la Torre M.D.L., Rodrigues A.G.P., Tome A.C., Silva A.M.S., and Cavaleiro J.A.S. Tetrahedron 60 (2004) 3581
19. de la Torre M.D.L., Marcorin G.L., Pirri G., Tome A.C., Silva A.M.S., and Cavaleiro J.A.S. Tetrahed. Lett. 43 (2002) 1689
20. de la Torre M.D.L., Tome A.C., Silva A.M., and Cavaleiro J.A.S. Tetrahedron Lett. 43 (2002) 4617
21. Jialal I., Devaraj S., and Venugopal S.K. Free Radical Res. 36 (2002) 1331
22. Suryaprasad A.G., and Prindiville T. Autoimmunity Rev. 2 (2003) 346
23. Kulkarni R.G., Achaiah G., and Sastry G.N. Curr. Pharm. Des. 12 (2006) 2437
24. Komatsu W., Ishihara K., Murata M., Saito H., and Shinohara K. Free Radical Biol. Med. 34 (2003) 1006
25. Kammer G.M. Immunol. Today 9 (1988) 222
26. Odingo J.O. Expert Opin. Ther. Patents 15 (2005) 773
27. Krusic P.J., Wassermann E., Keizer P.N., Morton J.R., and Preston K.F. Science 254 (1991) 1183
28. Yamakoshi Y., Umexawa N., Ryu A., Arakane K., Miyata N., and Goda Y. J. Am. Chem. Soc. 125 (2003) 12803
29. Gharbi N., Pressac M., Hadchouel M., Szwarc H., Wilson S.R., and Moussa F. Nano Lett. 5 (2005) 2578
30. Satoh M., Matsuo K., Takanashi Y., and Takayanagi I. Gen. Pharmacol. 26 (1995) 1533
31. Satoh M., Matsuo K., Kiriya H., Mashino T., Nagano T., and Hirobe M. Eur. J. Pharmacol. 327 (1997) 175
32. Satoh M., Mashino T., Nagano T., Hirobe M., and Takayanagi I. Fullerene Sci. Technol. 9 (2001) 141
33. Horrigan L.A., Kelly J.P., and Connor T.J. Pharm. & Ther. 11 (2006) 877
34. Cottam H.B., Shih H., Tehrani L.R., Wasson D.B., and Carson D.A. J. Med. Chem. 39 (1996) 2
35. Tzeng S.-F., Lee J.-L., Kuo J.-S., Yang C.-S., Murugan P., Tai L.A., and Hwang K.C. Brain Res. 940 (2002) 61
36. Kordatos K., Da Ros T., Bosi S., Vázquez E., Bergamin M., Cusan C., Pellarini F., Véronique T., Benedetta B., Davide P., Georgakilas V., Giampiero S., and Prato M. J. Org. Chem. 66 (2001) 4915
37. Wolleb H., and Pfander H. Helv. Chim. Acta. 69 (1986) 1505
38. (a) The detail spectra descriptions for all of synthesized compounds are listed in Supplementary data. (b) The synthetic scheme of 3 is also provided in Supplementary data.
39. The UV-vis spctra of 2a, b and 3 in 1% DMSO aqueous sloutions showed that the main absorption of the fullerene core was still evident, although, in analogy to other fullerene derivatives dissolved in polar solvents, the bands are broader and less structured, especially in the low-energy region (Supplementary data). Da Ros T., and Prato M. J. Org. Chem. 61 (1996) 9070
40. Suarez M., Verdcia Y., Illescas B., Martinez-Alvarez R., Alvarez A., Ochoa E., Seoane C., Kayali N., and Martin N. Tetrahedron 59 (2003) 9179
41. Illescas B., Martinez-Grau M.A., Torres M.L., Fernandez-Gadea J., and Martin N. Tetrahedron Lett. 43 (2002) 4133
42. Illescas B.M., Martinez-Alvarez R., Fernandez-Gadea J., and Martin N. Tetrahedron 59 (2003) 6569
43. Ralph P., Prichard J., and Cohn M. J. Immunol. 114 (1975) 898
44. Huang S.T., Tsai H.D., Kuo H.S., Yang Y.P., Peng Y.C., and Lin Y.L. Chem. Bio. Chem. 5 (2004) 797
45. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., and Wishnok J.S. Anal. Biochem. 126 (1982) 131
46. Cho J.Y., Park J., Yoo E.S., Yoshikawa K., Baik K.U., and Lee J. Arch. Pharm. Res. 21 (1998) 12
47. Beshay E., Croze F., and Prud'homme G. Clin. Immunol. 98 (2001) 272